Intra-Cellular Therapies (ITCI) Surged To A 4-Month High On FDA News

The FDA has informed Intra-Cellular Therapies (ITCI) that it agrees the company has provided adequate data and may proceed with its long-term safety study of lumateperone.

from RTT - Before the Bell http://ift.tt/2wqvyaz
via IFTTT